Viewing Study NCT04503798



Ignite Creation Date: 2024-05-06 @ 3:03 PM
Last Modification Date: 2024-10-26 @ 1:42 PM
Study NCT ID: NCT04503798
Status: UNKNOWN
Last Update Posted: 2020-08-07
First Post: 2020-08-05

Brief Title: Online Cognitive Rehabilitation of Executive Dysfunction in Nonamnestic MCI
Sponsor: Baycrest
Organization: Baycrest

Study Overview

Official Title: Rehabilitation of Executive Dysfunction in Nonamnestic MCI Using Online Goal Management Training
Status: UNKNOWN
Status Verified Date: 2020-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Nonamnestic mild cognitive impairment naMCI is a prodromal state characterized by deficits in executive functioning a collection of higher-order abilities involved in organization planning inhibition and complex reasoning Research shows that individuals with naMCI have an increased risk of developing non-Alzheimers dementia such as frontotemporal dementia and dementia with Lewy bodies which pose substantial personal and societal costs Accordingly interventions that can successfully slow down or reverse the course of naMCI are needed

Goal Management Training GMT is a cognitive rehabilitation platform that has been studied extensively applied clinically and manualized into kits for clinicians Levine et al 2000 Levine et al 2007 Levine et al 2011 Stamenova Levine 2019 The purpose of GMT is to train individuals to periodically STOP what they are doing attend to task goals evaluate their performance and monitor or check outcomes as they proceed Recently an online version of GMT has been developed and validated in order to circumvent barriers to attending in-person sessions

The purpose of the current study is to determine if the online version of GMT is effective at improving self-reported executive dysfunction in individuals diagnosed with naMCI against a control group that is receiving treatment-as-usual from their care provider It is hypothesized that compared to the control group individuals receiving GMT will report a decrease in executive function deficits
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None